Kelai pens Double Rainbow pact to pair drug delivery and biosynthesis tech
Landkind launches LK-01 Pure Salidroside for cognitive and athletic performance
Bioengineering the Sustainable Future of Medicinal Plants
Double Rainbow launches Landkind to deliver a new class of sustainable wellness products
Cutting the carbon footprint of pharma’s supply chain
Could Sugar Hold the Key to Cancer?
Pharma Sets a Foundation for Greener API Manufacturing
Is Poor Bioavailability Holding Back Modern Medicine?
2021: A year in Review
Double Rainbow announces $10 million investment from Betta Pharmaceuticals
